| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $88.0M | +376.6% |
| R&D Expense | $416.0M | +22.6% |
| SG&A Expense | $284.3M | +32.0% |
| Operating Income | -$612.3M | -14.2% |
| Interest Expense | $45.6M | +20.9% |
| Income Tax | $0 | — |
| Net Income | -$785.0M | -33.2% |
| EPS (Basic) | -$6.54 | -24.3% |
| EPS (Diluted) | -$6.54 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.5M | +29.2% |
| Accounts Receivable | $17.8M | +6.7% |
| Current Assets | $917.0M | -17.2% |
| Total Assets | $1.42B | +1.6% |
| Current Liabilities | $202.5M | +12.7% |
| Long-term Debt | $246.4M | -60.2% |
| Total Liabilities | $2.08B | +35.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$510.0M | -28.8% |
| Capital Expenditures | $24.8M | +535.1% |
| Investing Cash Flow | $16.7M | +103.0% |
| Financing Cash Flow | $524.5M | -43.6% |
| Free Cash Flow | -$534.8M | -33.8% |
| -24.3% |
| Stockholders' Equity |
| -$659.6M |
| -387.3% |